Hoelscher Paul W. has filed 4 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 32250 shares of Sagimet Biosciences Inc. ($SGMT) on June 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 9, 2025 | Sagimet Biosciences Inc. | $SGMT | Hoelscher Paul W. | Director | A | Stock Option (Right to Buy) | 32250 | $0.00 | 32,250.0000 | 32,195,345 | 9999.99% | 0.10% |
| June 5, 2024 | Sagimet Biosciences Inc. | $SGMT | Hoelscher Paul W. | Director | A | Stock Option (Right to Buy) | 9279 | $0.00 | 9,279.0000 | 29,039,427 | 9999.99% | 0.03% |
| April 1, 2024 | Sagimet Biosciences Inc. | $SGMT | Hoelscher Paul W. | Director | A | Stock Option (Right to Buy) | 73014 | $0.00 | 73,014.0000 | 29,039,427 | 9999.99% | 0.25% |
| June 6, 2023 | OnKure Therapeutics, Inc. | $OKUR | Hoelscher Paul W. | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |